Mediwart Pharmaceuticals Llp - Company Profile

It is a electrnoics limited liability partnership based in Jodpur, Rajasthan, India, established in 2016.
2016 Jodpur, Rajasthan, India Active
Last Updated:
Access Report
About Mediwart Pharmaceuticals Llp

Mediwart Pharmaceuticals Llp, a active limited liability partnership, was established on 15 September 2016 in Jodpur, Rajasthan, India. Engaging in medical within the electrnoics sector, it holds LLPIN: AAH-3960. Registered under ROC Roc Jaipur. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Dharamveer Jindal (Designated Partner), Suresh Panwar (Designated Partner). It holds ₹1.50 M open charges and ₹0.35 M settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Shop No. 04, Plot No. 63, Raikabagh Bank Colony Ummed Bhawan Road, Jodpur, Rajasthan, 342001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAH-3960

  • Incorporation Date

    15 September 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.50 M
  • Satisfied Charges ₹ 0.35 M
Company report

Mediwart Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mediwart Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Mediwart Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Dharamveer Jindal Designated Partner 15 Sep 2016 Current
Suresh Panwar Designated Partner 15 Sep 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mediwart Pharmaceuticals Llp.

Enhance accessibility to Mediwart Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mediwart Pharmaceuticals Llp revenue growth over time
Mediwart Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mediwart Pharmaceuticals Llp?

Unlock access to Mediwart Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,500,000.00

Satisfied Charges

₹350,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
13 Jan 2025 Canara Bank ₹1.50 M Open
09 Jan 2019 Punjab National Bank (Formerly Oriental Bank Of Commerce) ₹0.35 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Mediwart Pharmaceuticals Llp?

Unlock and access historical data on people associated with Mediwart Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mediwart Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediwart Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mediwart Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Mediwart Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Mediwart Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was completed.

  • Charges

    Progress on A charge registered on 09 Jan 2019 via Charge ID 100232875 with Punjab National Bank (Formerly Oriental Bank Of Commerce) was fully satisfied on 06 Feb 2025. was documented.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 1.50 M with Charge ID 101036084 was registered on 13 Jan 2025. was completed.

  • Charges

    The activity A charge with Punjab National Bank (Formerly Oriental Bank Of Commerce) amounted to Rs. 0.35 M with Charge ID 100232875 was registered on 09 Jan 2019. was completed.

  • Director Appointment

    Progress on Dharamveer Jindal was appointed as a Designated Partner was appointed as a Designated Partner on 15 Sep 2016 & has been associated with this company since 9 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Mediwart Pharmaceuticals Llp?

The LLPIN of Mediwart Pharmaceuticals Llp is AAH-3960.

Where is Mediwart Pharmaceuticals Llp headquartered?

Mediwart Pharmaceuticals Llp is headquartered at Shop No. 04, Plot No. 63, Raikabagh Bank Colony Ummed Bhawan Road, Jodpur, Rajasthan, 342001.

When was Mediwart Pharmaceuticals Llp incorporated?

Mediwart Pharmaceuticals Llp was incorporated on 15 September 2016.

Who are the current directors of Mediwart Pharmaceuticals Llp?

The current directors of Mediwart Pharmaceuticals Llp are

What is the primary industry of Mediwart Pharmaceuticals Llp?

The primary industry of Mediwart Pharmaceuticals Llp is Electrnoics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available